Small RNA Profiling in an HTLV-1-Infected Patient with Acute Adult T-Cell Leukemia-Lymphoma at Diagnosis and after Maintenance Therapy: A Case Study

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Autores
PESSOA, Rodrigo
SOUZA, Daniela Raguer Valadao de
FERNANDES, Lorena Abreu
MARCUSSO, Rosa Nascimento
OLIVEIRA, Augusto Cesar Penalva de
Citação
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v.24, n.13, article ID 10643, 15p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Small RNAs (sRNAs) are epigenetic regulators of essential biological processes associated with the development and progression of leukemias, including adult T-cell leukemia/lymphoma (ATLL) caused by human T-cell lymphotropic virus type 1 (HTLV-1), an oncogenic human retrovirus originally discovered in a patient with adult T-cell leukemia/lymphoma. Here, we describe the sRNA profile of a 30-year-old woman with ATLL at the time of diagnosis and after maintenance therapy with the aim of correlating expression levels with response to therapy.
Palavras-chave
small RNA, HTLV-1, ATLL, massive parallel sequencing
Referências
  1. Agha DM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197065
  2. Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167
  3. Al Sharif S, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12121422
  4. Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803
  5. Ariumi Y, 2000, ONCOGENE, V19, P1491, DOI 10.1038/sj.onc.1203450
  6. Batlle E, 2019, IMMUNITY, V50, P924, DOI 10.1016/j.immuni.2019.03.024
  7. Bazarbachi A, 1999, BLOOD, V93, P278, DOI 10.1182/blood.V93.1.278.401k22_278_283
  8. Bazarbachi A, 2011, BLOOD, V118, P1736, DOI 10.1182/blood-2011-03-345702
  9. Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085
  10. Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30
  11. Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106
  12. Clissa PB, 2016, DATA BRIEF, V9, P685, DOI 10.1016/j.dib.2016.09.052
  13. D'Agostino DM, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.974088
  14. Datta A, 2006, BLOOD, V108, P1021, DOI 10.1182/blood-2006-01-0067
  15. Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233
  16. Dong N, 2014, MOL CELL BIOCHEM, V396, P229, DOI 10.1007/s11010-014-2158-4
  17. El-Sabban ME, 2000, BLOOD, V96, P2849
  18. ELDEIRY WS, 1994, CANCER RES, V54, P1169
  19. Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629
  20. Franchini Genoveffa, 2000, Hematology Am Soc Hematol Educ Program, P409
  21. Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398
  22. Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388
  23. Gorur A, 2013, MOL BIOL REP, V40, P2091, DOI 10.1007/s11033-012-2267-7
  24. Gottmann P, 2018, MOL METAB, V11, P145, DOI 10.1016/j.molmet.2018.03.005
  25. Hachiman M, 2018, ONCOL LETT, V16, P1305, DOI 10.3892/ol.2018.8771
  26. Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054
  27. Higuchi C, 2015, METABOLISM, V64, P489, DOI 10.1016/j.metabol.2014.12.003
  28. Higuchi M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-117
  29. Hudson RS, 2013, ONCOGENE, V32, P4139, DOI 10.1038/onc.2012.424
  30. Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936
  31. Inoshita S, 1999, KIDNEY INT, V56, P1238, DOI 10.1046/j.1523-1755.1999.00705.x
  32. Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105
  33. Jiang X, 2012, CANCER CELL, V22, P524, DOI 10.1016/j.ccr.2012.08.028
  34. Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002
  35. Kim BG, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01053-x
  36. KIM SJ, 1990, J EXP MED, V172, P121, DOI 10.1084/jem.172.1.121
  37. Lee J, 2019, BREAST CANCER RES TR, V176, P119, DOI 10.1007/s10549-019-05192-1
  38. Li BK, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0226-4
  39. Li CY, 2019, CHINESE MED J-PEKING, V132, P2213, DOI 10.1097/CM9.0000000000000427
  40. Li JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099442
  41. Li NN, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.119
  42. Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x
  43. Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808
  44. Lin XC, 2017, INT J ONCOL, V50, P671, DOI 10.3892/ijo.2016.3832
  45. Lu L, 2019, J CANCER, V10, P3389, DOI 10.7150/jca.31676
  46. Luo KX, 1997, EMBO J, V16, P1970, DOI 10.1093/emboj/16.8.1970
  47. Marcuello M, 2019, CANCERS, V11, DOI 10.3390/cancers11101542
  48. Marquez ME, 2022, CANCERS, V14, DOI 10.3390/cancers14071676
  49. Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046
  50. Motsch N, 2007, RNA BIOL, V4, P131, DOI 10.4161/rna.4.3.5206
  51. Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100
  52. MURPHY EL, 1989, INT J CANCER, V43, P250, DOI 10.1002/ijc.2910430214
  53. Nabhan M, 2017, GENE, V628, P253, DOI 10.1016/j.gene.2017.07.052
  54. Nagata Y, 2016, BLOOD, V127, P596, DOI 10.1182/blood-2015-06-644948
  55. Nahand JS, 2020, IUBMB LIFE, V72, P343, DOI 10.1002/iub.2222
  56. Nakano K, 2016, CLIN CANCER RES, V22, P5915, DOI 10.1158/1078-0432.CCR-15-1739
  57. Nascimento A, 2021, INFECT AGENTS CANCER, V16, DOI 10.1186/s13027-020-00343-2
  58. Nasr R, 2003, BLOOD, V101, P4576, DOI 10.1182/blood-2002-09-2986
  59. Nicot C, 2001, MOL CELL BIOL, V21, P7391, DOI 10.1128/MCB.21.21.7391-7402.2001
  60. NIITSU Y, 1988, BLOOD, V71, P263
  61. Ooi A, 2017, HUM PATHOL, V61, P58, DOI 10.1016/j.humpath.2016.10.025
  62. Peng QL, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06863-9
  63. Pichler K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-100
  64. Pise-Masison CA, 2000, MOL CELL BIOL, V20, P3377, DOI 10.1128/MCB.20.10.3377-3386.2000
  65. POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
  66. SAKASHITA A, 1992, BLOOD, V79, P477
  67. Sampath D, 2009, BLOOD, V113, P3744, DOI 10.1182/blood-2008-09-178707
  68. SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x
  69. Si WG, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-018-0587-8
  70. Sun G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/687826
  71. Tanha HM, 2016, TUMOR BIOL, V37, P7861, DOI 10.1007/s13277-015-4553-1
  72. Tomita M, 2012, INT J CANCER, V130, P2300, DOI 10.1002/ijc.25115
  73. Ungefroren H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-67
  74. de Souza DRV, 2020, ONCOL LETT, V20, P2311, DOI 10.3892/ol.2020.11803
  75. van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089
  76. Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x
  77. Verboon LJ, 2016, ONCOTARGET, V7, P48412, DOI 10.18632/oncotarget.10270
  78. Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6
  79. Wang F, 2015, ONCOL LETT, V10, P11, DOI 10.3892/ol.2015.3170
  80. Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557
  81. Wang XD, 2018, GENE, V665, P6, DOI 10.1016/j.gene.2018.04.065
  82. Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81
  83. Xu Ling, 2011, Zhonghua Xue Ye Xue Za Zhi, V32, P178
  84. Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1
  85. Yamada Y, 2001, BRIT J HAEMATOL, V113, P375, DOI 10.1046/j.1365-2141.2001.02737.x
  86. Yamagishi M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00334
  87. Yang TS, 2014, FEBS LETT, V588, P2162, DOI 10.1016/j.febslet.2014.04.050
  88. Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769
  89. YOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534
  90. Yu D, 2014, LAB INVEST, V94, P1370, DOI 10.1038/labinvest.2014.125
  91. Yu SR, 2017, ANTI-CANCER DRUG, V28, P852, DOI 10.1097/CAD.0000000000000524
  92. Yuan C, 2019, ONCOL LETT, V18, P1979, DOI 10.3892/ol.2019.10495
  93. Zanette DL, 2007, BRAZ J MED BIOL RES, V40, P1435, DOI 10.1590/S0100-879X2007001100003
  94. Zhang MY, 2021, BLOOD, V138, DOI 10.1182/blood-2021-152517
  95. Zhang WC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11702
  96. Zhao TJ, 2011, BLOOD, V118, P1865, DOI 10.1182/blood-2010-12-326199
  97. Zheng LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055719
  98. Zheng RH, 2015, J SURG RES, V195, P158, DOI 10.1016/j.jss.2014.12.035